Ultraquin Plain 4% Hydroquinone Cream USP
Originaltext auf Französisch.
Ultraquin Plain 4% Hydroquinone Cream USP, 00632783: in Kanada zugelassenes Naturgesundheitsprodukt. Medizinische Inhaltsstoffe: Hydroquinone.
Die Analyse oraler Dosen ist ohne einen nachgewiesenen ausschließlich oralen Verabreichungsweg nicht anwendbar.
Zusammensetzung
| Arzneilicher Inhaltsstoff und Quelle | Je Dosiseinheit laut Quelle |
|---|---|
| Hydroquinone | 4 % (p/p) |
Nicht arzneiliche Inhaltsstoffe
Octyldodecyl Stearoyl Stearate, Métabisulfite de sodium, Eau purifiée, Chlorure de benzalkonium, propylèneglycol, Mineral oil, PolyDimethylsiloxane / Polymethylsilesquioxane Copolymer, Octyl Palmitate, Hydroxy methyl cellulose, EDTA de sodium, Acide ascorbique, Emulgate PL 68-50, Stéarate de glycéryle, Quaternium - 15, Acide phosphorique
In Kanada empfohlene Dosen
| Bevölkerungsgruppe | Alter | Menge pro Einnahme | Häufigkeit |
|---|---|---|---|
| Adultes | Non précisée | Non précisée | minimum : 1 Tous les jours ; maximum : 2 Tous les jours |
| Enfants | minimum : 12 ans | Non précisée | minimum : 1 Tous les jours ; maximum : 2 Tous les jours |
In Kanada zugelassene Verwendungen
To lighten hyperpigmented skin, fade skin discolorations and lighten freckles and " age spots".
Originaltext auf Französisch.
Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.
Warnhinweise in Kanada
Cautions and Warnings : To be used only on the advice of a physician. For external use only. Use only as directed. Avoid contact with eyes, mucous membranes and broken or irritated skin. In case of contact, rinse thoroughly with water. Do only apply over sunburn or irritated skin. Test for sensitivity. Apply only to small skin surface area. Discontinue sue and consult a physician in case of skin reactions or a blue-black darkening of the skin. A mild transient stinging or minor redness may occur in people with sensitive skin. To test for sensitivity, before treatment, apply to n an area of approximately 1 cm2 of unbroken skin on the inside of the arm. If no irritation occurs within 24 hours, begin treatment for up to 12 weeks. Discontinue sue in case of irritation, rash, excessive inflammatory response or if gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but where there is an excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which case the product should be discontinued and the physician notified immediately. The safety of topical hydroquinone use during pregnancy or children 12 years old or less has not been established. Do not use this product if you have used it or any of its ingredients before and skin sensitivity or irritation has occurred. Do not use this product if you are nursing, pregnant or if you intend to become pregnant within 3 months of use. If you have a family history or, have or have had or at risk of developing cancer, do not use. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this product. Close patient supervision is recommended. A bitter taste and anesthetic effect may occur if applied to lips. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Treatment should be limited to relatively small areas of the body at one time. Keep out of reach of children. Not for use on children under 12 years of age. In case of accidental ingestion, seek medical assistance or contact Poison Control Center immediately. Note: Slight darkening of the product is normal when exposed to air and does not affect its potency. When this happens, extract a tiny amount of product, clean with a cotton swab and discard prior to use. If the entire contents become brown, discontinue use and consult a physician. Store at room temperature.
Originaltext auf Englisch.
Produktdaten
- Inhaber
- Opella Canada Inc.
- NPN oder DIN-HM
- 00632783
- Status
- Lizenz nicht aktiv
- Lizenzdatum
- 11. Januar 2008
- Überarbeitungsdatum
- 8. April 2014
- Form
- Crème
- Verabreichungsweg
- Topique
- Art des Antrags
- DIN de transition
Quelle
Amtlicher Health-Canada-Eintrag, Zulassung 00632783
Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Originaltext auf Englisch.
Originaltext auf Französisch.
Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.
Liste in der amtlichen Überarbeitung vom (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).
Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.